{"nct_id":"NCT02335918","title":"A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors","status":"COMPLETED","status_verified_date":"2018-11","start_date":"2015-01","start_date_type":null,"primary_completion_date":"2018-12-12","primary_completion_date_type":"ACTUAL","completion_date":"2018-12-12","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["CLDX"]}